199 related articles for article (PubMed ID: 8186277)
1. Out-patient medical care in Edinburgh for IDU-related HIV.
Brettle RP; Willocks L; Hamilton BA; Shaw L; Leen CL; Richardson A; Gore SM
AIDS Care; 1994; 6(1):49-58. PubMed ID: 8186277
[TBL] [Abstract][Full Text] [Related]
2. Psychoeducational group approach: HIV risk reduction in drug users.
Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
[TBL] [Abstract][Full Text] [Related]
3. Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance.
Stein MD; Urdaneta ME; Clarke J; Maksad J; Sobota M; Hanna L; Markson LE
J Addict Dis; 2000; 19(1):85-94. PubMed ID: 10772605
[TBL] [Abstract][Full Text] [Related]
4. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
Serpelloni G; Carrieri MP; Rezza G; Morganti S; Gomma M; Binkin N
AIDS Care; 1994; 6(2):215-20. PubMed ID: 8061081
[TBL] [Abstract][Full Text] [Related]
5. On-site medical care in methadone maintenance: associations with health care use and expenditures.
Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
[TBL] [Abstract][Full Text] [Related]
6. Outpatient medical care of injection drug use related HIV.
Brettle RP; Gore SM; McNeil A
Int J STD AIDS; 1992; 3(2):96-100. PubMed ID: 1315159
[TBL] [Abstract][Full Text] [Related]
7. Self-reported reasons among HIV-infected patients for missing clinic appointments.
Park WB; Kim JY; Kim SH; Kim HB; Kim NJ; Oh MD; Choe KW
Int J STD AIDS; 2008 Feb; 19(2):125-6. PubMed ID: 18334069
[TBL] [Abstract][Full Text] [Related]
8. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
[TBL] [Abstract][Full Text] [Related]
9. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
Weiss SH; Weston CB; Quirinale J
AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708
[TBL] [Abstract][Full Text] [Related]
10. [Substitution as a possibility for the treatment of opiate dependent patients].
von Bardeleben U; Petitjean S; Stohler R; Natsch C; Ladewig D
Psychiatr Prax; 1994 Jan; 21(1):7-9. PubMed ID: 8146246
[TBL] [Abstract][Full Text] [Related]
11. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
[TBL] [Abstract][Full Text] [Related]
12. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
[TBL] [Abstract][Full Text] [Related]
13. Missed appointments in an outpatient clinic for adolescents, an approach to predict the risk of missing.
Chariatte V; Berchtold A; Akré C; Michaud PA; Suris JC
J Adolesc Health; 2008 Jul; 43(1):38-45. PubMed ID: 18565436
[TBL] [Abstract][Full Text] [Related]
14. Compliance with return appointments for reproductive health care among adolescent Norplant users.
Rainey DY; Parsons LH; Kenney PG; Krowchuk DP
J Adolesc Health; 1995 May; 16(5):385-8. PubMed ID: 7662689
[TBL] [Abstract][Full Text] [Related]
15. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
Fhima A; Henrion R; Lowenstein W; Charpak Y
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
17. [HIV prevention in HIV-positive drug addicts. A methadone-supported model].
Oertle D; Edelmann R; Ostewalder J; Vernazza PL; Galeazzi RL
Schweiz Med Wochenschr; 1993 Dec; 123(48):2284-92. PubMed ID: 8272803
[TBL] [Abstract][Full Text] [Related]
18. Predictors of outcome in methadone programs: effect of HIV counseling and testing.
Farley TA; Cartter ML; Wassell JT; Hadler JL
Conn Med; 1994 Mar; 58(3):165-71. PubMed ID: 8039381
[TBL] [Abstract][Full Text] [Related]
19. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
Spire B; Lucas GM; Carrieri MP
Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
[TBL] [Abstract][Full Text] [Related]
20. Observational analysis of German injecting drug users (IDU): survival with and without methadone maintenance treatment. German AIDS Study Group GASG/IdkF.
Eur J Med Res; 1996 Jan; 1(4):209-14. PubMed ID: 9445761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
